{
    "code": "01050114",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01050114",
    "time": "2019-04-12 03:37:52",
    "許可證字號": "衛署藥製字第050114號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/04\/28",
    "發證日期": "98\/04\/28",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00105011408",
    "中文品名": "復憶能 膠囊 4.5 毫克",
    "英文品名": "Revelin Capsules 4.5 mg",
    "適應症": "輕度至中度阿茲海默氏病之癡呆 (失智) 症。與帕金森氏症相關的輕度至中度癡呆 (失智) 症。",
    "劑型": "130膠囊劑",
    "包裝": "4~1000粒塑膠瓶裝 4~1000粒鋁箔盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "RIVASTIGMINEHYDROGENTARTRATE"
    ],
    "限制項目": "01國　產 24監視期滿學名藥 61完成BE試驗",
    "申請商名稱": "1304820200  瑞士藥廠股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "6105200026  瑞士藥廠股份有限公司新市廠",
        "製造廠廠址": "台南市新市區中山路182號",
        "製造廠公司地址": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1204001410",
            "成分名稱": "RIVASTIGMINE HYDROGEN TARTRATE",
            "含量描述": "(eq. to rivastigamine 4.5mg)",
            "含量": "7.2000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "復憶能 膠囊 4.5 毫克01050114仿單-105-10-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01050114&Seq=002&Type=9"
        },
        {
            "title": "復憶能 膠囊 4.5 毫克01050114鋁箔-105-10-28.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01050114&Seq=006&Type=8"
        }
    ]
}